587 reports of this reaction
3.8% of all IOHEXOL reports
#4 most reported adverse reaction
SNEEZING is the #4 most commonly reported adverse reaction for IOHEXOL, manufactured by GE Healthcare. There are 587 FDA adverse event reports linking IOHEXOL to SNEEZING. This represents approximately 3.8% of all 15,311 adverse event reports for this drug.
Patients taking IOHEXOL who experience sneezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SNEEZING is moderately reported among IOHEXOL users, representing a notable but not dominant share of adverse events.
In addition to sneezing, the following adverse reactions have been reported for IOHEXOL:
The following drugs have also been linked to sneezing in FDA adverse event reports:
SNEEZING has been reported as an adverse event in 587 FDA reports for IOHEXOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
SNEEZING accounts for approximately 3.8% of all adverse event reports for IOHEXOL, making it a notable side effect.
If you experience sneezing while taking IOHEXOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.